Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 193

Results For "EMA"

2243 News Found

U.S. FDA approves Alembic’s Formoterol Fumarate inhalation solution
Drug Approval | November 23, 2021

U.S. FDA approves Alembic’s Formoterol Fumarate inhalation solution

The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies


Philips integrates MedChat’s AI to optimise automated patient communication
Digitisation | November 23, 2021

Philips integrates MedChat’s AI to optimise automated patient communication

Hospitals and outpatient clinics can also digitally navigate patients from the time an order is placed, to when it is scheduled and completed through follow-up


Molbio has pioneered point of care molecular testing: Sriram Natarajan
interviews | November 22, 2021

Molbio has pioneered point of care molecular testing: Sriram Natarajan

Molbio Diagnostics has been the pioneer in providing access to molecular testing through its Truenat Real Time PCR platform. Sriram Natarajan, Director & CEO, of the company shares his experiences on the journey so far in an interview with Thomas C Thottathil


Amneal gets approval for Difluprednate ophthalmic emulsion
Drug Approval | November 22, 2021

Amneal gets approval for Difluprednate ophthalmic emulsion

The company is moving towards complex and more differentiated products


FDA grants Theradaptive Breakthrough Medical Device designation
Medical Device | November 22, 2021

FDA grants Theradaptive Breakthrough Medical Device designation

Theradaptive's regenerative implants are best-in-class and are designed to permit precise tissue regeneration for a variety of tissue types and clinical indications


Merck showcases potential for several cancers, MS and lupus
News | November 22, 2021

Merck showcases potential for several cancers, MS and lupus

Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline


Oravax and Genomma JV to commercialise Covid-19 vaccine in Mexico and Latam
Biotech | November 20, 2021

Oravax and Genomma JV to commercialise Covid-19 vaccine in Mexico and Latam

Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical


Funding push to pharma R&D critical for unleashing next phase of growth
News | November 20, 2021

Funding push to pharma R&D critical for unleashing next phase of growth

The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation


Flipkart acquires SastaSundar, an online pharmacy and healthcare platform
Startup | November 20, 2021

Flipkart acquires SastaSundar, an online pharmacy and healthcare platform

Flipkart also announced its foray into the healthcare sector through the launch of Flipkart Health+


Indian nutraceutical market is expected to touch US $ 18 bn by 2025: Dr R.B Smarta
interviews | November 18, 2021

Indian nutraceutical market is expected to touch US $ 18 bn by 2025: Dr R.B Smarta

The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector